Dr. Weber on Nivolumab Versus Chemotherapy in Advanced Melanoma

Dr. Weber on Nivolumab Versus Chemotherapy in Advanced Melanoma

Jeffrey S. Weber, MD, PhD, medical oncologist, Moffitt Cancer Center, discusses the results of a phase III randomized, open-label study of nivolumab compared with investigator's choice chemotherapy for the treatment of patients with advanced melanoma after prior anti-CTLA-4 therapy. More from ESMO: http://www.onclive.com/conference-cov...